Heterocyclic diones of the class containing 3-(heteroarylalkylene)- and 3(arylalkylene)-2, 4 (3H, 5H)-furandiones, and 3-(heteroarylalkylene)-pyrrolidene diones and -thiophene diones are disclosed as being effective cancer chemotherapy drugs, some of which are themselves novel compounds. Various members of this class were tested both in vitro and in vivo to demonstrate their effectiveness at reducing or inhibiting cancer tumor cells. The class of drugs was evaluated against a series of 10 human tumors in the in vitro Human Tumor Cell Assay procedure. The procedure indicates that this class of heterocyclic diones is effective against a broad variety of types of cancer and has little or no toxic effects based upon hematological and pathological evaluations.
这类含有3-(杂环芳基烷基)-和3(芳基烷基)-2,4(3H,5H)-
呋喃二酮,以及3-(杂环芳基烷基)-
吡咯烷二酮和-
噻吩二酮的杂环二酮被披露为有效的癌症化疗药物,其中一些是新颖的化合物。这一类药物的各种成员在体外和体内进行了测试,以证明它们在减少或抑制癌症肿瘤细胞方面的有效性。该类药物被评估对抗一系列10种人类肿瘤的体外人类肿瘤细胞测定程序。该程序表明,这类杂环二酮对多种类型的癌症具有有效作用,并且根据血液学和病理学评估几乎没有毒性作用。